BDBM622059 US20230312550, Example 19

SMILES O=C(CNC(=O)c1ccnc2ccc(cc12)N1CCC11CCC1)N1CSC[C@H]1C#N

InChI Key InChIKey=NYJCGFBNRXRVEK-MRXNPFEDSA-N

Data  3 IC50  1 Kd  1 Koff  1 Kon

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 622059   

TargetPresequence protease, mitochondrial(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM622059(US20230312550, Example 19)
Affinity DataIC50:  160nMAssay Description:Table 3: Compounds were tested in a biochemical inhibition assay using Prolyl endopeptidase, Prolyl Oligopeptidase (hPREP) enzyme at 0.6 nM FAC (R&D ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProlyl endopeptidase FAP(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM622059(US20230312550, Example 19)
Affinity DataKoff:  4.30E+5s-1Assay Description:Table 1: Compounds were tested in a direct binding assay using 8K surface plasmon resonance biosensor (GE Healthcare) at 20° C. Immobilization of hFA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProlyl endopeptidase FAP(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM622059(US20230312550, Example 19)
Affinity DataKd:  0.150nMAssay Description:Table 1: Compounds were tested in a biochemical inhibition assay using human Fibroblast activation protein alpha (hFAP) enzyme at 2.4 pM FAC (Protero...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProlyl endopeptidase FAP(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM622059(US20230312550, Example 19)
Affinity DataIC50:  0.660nMAssay Description:Table 1: Compounds were tested in a direct binding assay using 8K surface plasmon resonance biosensor (GE Healthcare) at 20° C. Immobilization of hFA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProlyl endopeptidase FAP(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM622059(US20230312550, Example 19)
Affinity DataIC50:  0.380nMAssay Description:Table 1: Compounds were tested in a biochemical inhibition assay using hFAP enzyme at 0.24 nM FAC (Proteros, 38-760 (PR-0071)) and the substrate Ala-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProlyl endopeptidase FAP(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM622059(US20230312550, Example 19)
Affinity DataKon:  0.0000660M-1s-1Assay Description:Table 1: Compounds were tested in a direct binding assay using 8K surface plasmon resonance biosensor (GE Healthcare) at 20° C. Immobilization of hFA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent